Summary: New research reveals that cats with dementia show brain changes very similar to those seen in human Alzheimer’s disease, including toxic amyloid-beta accumulation at synapses. These changes disrupt communication between neurons and are linked to declines in memory and cognition.
The study also found that brain support cells actively remove the damaged synapses—a normally helpful process that, when excessive, may accelerate cognitive decline. Because these changes develop naturally in cats, feline cognitive dysfunction may offer a more accurate and humane model for studying Alzheimer’s and testing future therapies for both cats and people.
Key Facts:
- Shared disease mechanism: Cats with dementia show amyloid-beta accumulation in synapses, a central feature of Alzheimer’s disease in humans.
- Synapse loss and cognitive decline: Damaged synapses are cleared by glial support cells, and this loss correlates with impaired memory and thinking.
- Improved research model: Naturally occurring feline dementia may be a more relevant translational model than genetically engineered rodent systems.
Source: University of Edinburgh
Cats with dementia display Alzheimer’s-like brain pathology, offering a useful model for human research, according to a new study.
Researchers identified a buildup of the toxic protein amyloid-beta in the brains of cats affected by cognitive dysfunction. Amyloid-beta accumulation is one of the defining pathological features of Alzheimer’s disease in people, and its presence in feline brains strengthens the biological parallels between the two conditions.
The findings clarify how amyloid-beta may contribute to age-related brain dysfunction and memory problems in cats, and they suggest mechanisms that are relevant to human Alzheimer’s disease.
Like people, many older cats develop cognitive decline that causes noticeable behavioural changes—such as increased vocalisation, disorientation, altered social interactions and disrupted sleep—which mirror symptoms of Alzheimer’s disease.
To investigate these changes, scientists at the University of Edinburgh examined the brains of 25 cats of varying ages after death, including individuals that showed clinical signs of cognitive dysfunction.
High-resolution microscopy revealed amyloid-beta accumulation within synapses, the tiny junctions that enable neuron-to-neuron communication, in both aged cats and those with dementia. Because synapses are essential for information flow in the brain, their impairment or loss is strongly linked to declines in memory and cognition.
The team also observed that astrocytes and microglia—two types of glial support cells—were engulfing the affected synapses. Synaptic pruning by glia is a normal developmental process, but when it becomes dysregulated in aging or disease it can contribute to pathological synapse loss and worsening dementia.
Given the parallels between feline cognitive dysfunction and human Alzheimer’s disease, the authors suggest that naturally occurring pet cat dementia could help researchers better understand disease mechanisms and evaluate potential treatments that might benefit both species.
Historically, Alzheimer’s research has relied extensively on genetically modified rodent models. While those models provide valuable insight, rodents do not develop dementia naturally. Studying cats that develop age-related cognitive changes on their own may provide a more translationally relevant platform for studying disease progression and testing therapies.
The study was funded by Wellcome and the UK Dementia Research Institute and published in the European Journal of Neuroscience. The research team included scientists from the University of Edinburgh, the University of California, the UK Dementia Research Institute and Scottish Brain Sciences.
Dr Robert McGeachan, lead author from the University of Edinburgh’s Royal (Dick) School of Veterinary Studies, commented: “Dementia is a devastating disease—whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer’s disease in people.” He added that because cats naturally develop these brain changes, they may offer a more accurate model than traditional laboratory animals, potentially benefiting both species and their caregivers.
Professor Danièlle Gunn-Moore, Personal Chair of Feline Medicine at the Royal (Dick) School of Veterinary Studies, said: “Feline dementia is extremely distressing for both the cat and its owner. Studies like this are essential to learn how best to treat these animals. As a natural model of Alzheimer’s disease, feline cognitive dysfunction can help everyone—pets, owners, patients and families.”
About this dementia and Alzheimer’s disease research news
Author: Jessica Conway
Source: University of Edinburgh
Contact: Jessica Conway – University of Edinburgh
Image: The image is credited to Neuroscience News
Original Research: Open access. “Amyloid-Beta Pathology Increases Synaptic Engulfment by Glia in Feline Cognitive Dysfunction Syndrome: A Naturally Occurring Model of Alzheimer’s Disease” by Robert McGeachan et al. European Journal of Neuroscience. DOI: 10.1111/ejn.70180
Abstract
Amyloid-Beta Pathology Increases Synaptic Engulfment by Glia in Feline Cognitive Dysfunction Syndrome: A Naturally Occurring Model of Alzheimer’s Disease
Feline cognitive dysfunction syndrome (CDS), commonly known as feline dementia, is an age-related neurodegenerative disorder comparable to human dementia. It is marked by behavioural changes such as increased vocalisation, altered social interactions, shifts in the sleep–wake cycle, disorientation and house-soiling.
Although the exact mechanisms behind feline CDS are not fully understood, previous studies have identified pathologies in aged and CDS-affected cat brains that resemble Alzheimer’s disease, including brain atrophy, neuronal loss, amyloid-beta plaques, tau-related pathology and cerebral amyloid angiopathy.
Neuroinflammation and synapse loss—two other key features of human Alzheimer’s disease—may also play important roles in feline ageing and CDS, but they had not been systematically explored in cats until now.
In human Alzheimer’s disease and in mouse models of amyloidopathy, several mechanisms of synapse loss have been described, including synaptic accumulation of amyloid-beta and aberrant activation of synaptic engulfment by microglia and astrocytes.
This study used immunohistochemistry and confocal microscopy to examine the parietal cortex of young (n = 7), aged (n = 10) and CDS-affected (n = 8) cats. Statistical analysis showed that amyloid-beta accumulates within synapses in both aged and CDS-affected brains.
Additionally, the aged and CDS groups exhibited microgliosis and astrogliosis, along with increased synaptic engulfment by microglia and astrocytes in regions containing amyloid-beta plaques. Microglia and astrocytes also internalised amyloid-beta-rich synapses near plaques.
These results suggest that amyloid-beta has a pathogenic role in the feline brain and that the mechanisms of synapse loss mirror those seen in human Alzheimer’s disease. The findings support the use of feline CDS as a naturally occurring, translational model for Alzheimer’s, offering valuable insight into disease pathogenesis and potential therapeutic targets.